Work / Zuellig Pharma

Regional, Thailand, Philippines, Cambodia, Myanmar · Corporate Leadership & Reputation

Zuellig Pharma: A Healthcare Voice Across Four Markets

Zuellig Pharma moves medicine across Asia but is rarely seen doing it. Ruder Finn Era built one integrated programme across Thailand, the Philippines, Cambodia and Myanmar that put the company at the centre of the region's conversation on preventive health and healthcare access: 81 media placements and a reach of 89 million in five months, with three issues managed along the way.

The challenge

Zuellig Pharma's mission is to make healthcare more accessible across Asia, but a supply chain company works behind the brands people know, and awareness among the stakeholders who matter was thin. The brief was to make it a familiar, credible voice in healthcare across four markets: a thought leader with a stake in health outcomes, not a distributor.

Our solution

We built one programme for four markets, combining earned media, paid amplification and partnership led storytelling around the issues the region's health systems are living with: non communicable diseases, preventive health behaviours, healthcare access and equity, and sustainable healthcare supply.

Each market told the story through its own outlets and moments, from cold chain innovation in Thailand to hypertension in Myanmar and women's metabolic health in Cambodia, and the same team handled three issues as they arose, so the company's growing profile never ran ahead of its readiness.

The results

81+media placements in five months
89M+total reach across four markets
3issues managed

Within five months the programme generated more than 81 media placements and a reach of 89 million across the four markets, establishing Zuellig Pharma as a trusted voice in the regional healthcare conversation.

Client
Zuellig Pharma
Services
Executive and Thought Leadership, Crisis, Issues and Reputation, Behaviour Change and Education
Engagement
Retainer

Related work

Talk to the Regional team about work like this.